| Authors: |
Tan WP; Division of Urology, Duke University Medical Center, Durham, NC., Rastinehad AR; Department of Urology, Northwell Health, New York City, NY., Klotz L; Department of Urology, University of Toronto, Toronto, Ontario., Carroll PR; Department of Urology, University of California San Francisco, San Francisco, CA., Emberton M; Division of Surgery and Interventional Science, University College London, London, United Kingdom., Feller JF; HALO Diagnostics, Indian Wells, CA., George AK; Department of Urology, University of Michigan, Ann Arbor, MI., Gill IS; Department of Urology, University of Southern California, Los Angeles, CA., Gupta RT; Department of Radiology, Duke University Medical Center, Durham, NC., Katz AE; Department of Urology, New York University, New York City, NY., Lebastchi AH; Department of Urology, University of Southern California, Los Angeles, CA., Marks LS; Department of Urology, University of California Los Angeles, Los Angeles, CA., Marra G; L'Institut Mutualiste Montsouris, Paris, France., Pinto PA; Urologic Oncology Branch of the National Cancer Institute, Bethesda, MD., Song DY; Department of Radiation Oncology, Johns Hopkins University, Baltimore, MD., Sidana A; Department of Urology, University of Cincinnati, Cincinnati, OH., Ward JF; Department of Urology, MD Anderson Cancer Center, Houston, TX., Sanchez-Salas R; L'Institut Mutualiste Montsouris, Paris, France., Rosette J; Department of Urology, Istanbul Medipol University, Istanbul, Turkey., Polascik TJ; Division of Urology, Duke University Medical Center, Durham, NC. Electronic address: thomas.polascik@duke.edu. |
